Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd

Bullboard Posts

Post by movingup1on Jun 01, 2013 9:54am

190 Views

Post# 21470890

Boys are buying

John Greig bought a sh t load.i dont know if we should write off this pig just yet.my guess, we will be sold for 3 cents per share.ill take it.On another note, i just got out of jail again,cops said public intoxication,who gives a "F" c k if i had to pee behind a parked car, how in the "F" ck did i know some teenage girl was in there.all i said if she likes, all of a sudden 4 "F" ing Calgary finest tackle me down, i'm still not sure how i got in Alberta,well im out, and i have to get my welfare cheque,"F" ing office is closed till Monday.and i am thirsty.

Latest 10 SEDI filings (by filing date) for BLV within the last 6 months	[?]
Amended Filing

					As of 11:59pm ET May 31st, 2013
Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	# or value acquired or disposed of	Price
May 29/13	May 29/13	Greig, John Angus	Indirect Ownership	Common Shares	10 - Acquisition in the public market	600,000	$0.005
May 14/13	Apr 3/13	McInnes, Donald Arthur	Direct Ownership	Common Shares	10 - Acquisition in the public market	177,000	$0.005
May 7/13	May 3/13	McInnes, Donald Arthur	Direct Ownership	Common Shares	10 - Acquisition in the public market	323,000	$0.005
May 7/13	May 6/13	Douglas, David Mark	Direct Ownership	Common Shares	10 - Acquisition in the public market	15,000	$0.005
May 7/13	May 3/13	Douglas, David Mark	Direct Ownership	Common Shares	10 - Acquisition in the public market	485,000	$0.005
Mar 29/13	Mar 27/13	McInnes, Donald Arthur	Direct Ownership	Common Shares	10 - Acquisition in the public market	23,000	$0.005
Mar 27/13	Mar 26/13	McInnes, Donald Arthur	Direct Ownership	Options	52 - Expiration of options	-100,000	$0.470
Mar 25/13	Mar 25/13	McInnes, Donald Arthur	Direct Ownership	Common Shares	10 - Acquisition in the public market	15,000	$0.005
Mar 20/13	Mar 11/13	Douglas, David Mark	Direct Ownership	Common Shares	10 - Acquisition in the public market	500,000	$0.005
Mar 19/13	Mar 19/13	McInnes, Donald Arthur	Direct Ownership	Common Shares	10 - Acquisition in the public market	1,000	$0.005
Sign up for an account or login above to see all SEDI filings within the past 6 months.